Target and Cell Therapy for Atherosclerosis and CVD

Cardiovascular diseases (CVD) and, in particular, atherosclerosis, remain the main cause of death in the world today. Unfortunately, in most cases, CVD therapy begins after the onset of clinical symptoms and is aimed at eliminating them. In this regard, early pathogenetic therapy for CVD remains an...

Descripción completa

Detalles Bibliográficos
Autores principales: Markina, Yuliya V., Kirichenko, Tatiana V., Tolstik, Taisiya V., Bogatyreva, Anastasia I., Zotova, Ulyana S., Cherednichenko, Vadim R., Postnov, Anton Yu., Markin, Alexander M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299192/
https://www.ncbi.nlm.nih.gov/pubmed/37373454
http://dx.doi.org/10.3390/ijms241210308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299192/
https://www.ncbi.nlm.nih.gov/pubmed/37373454
http://dx.doi.org/10.3390/ijms241210308

Ejemplares similares